- €393.81m
- €726.61m
- €4.29bn
Brief: Bid On Cellularline Ineffective As Esprinet Fails To Reach Offer Threshold
Brief: Cellularline'S Investors Not To Tender Shares To Esprinet Bid Below EUR 5.2/Shr
Brief: 4 SIDE Says Antitrust Condition On Esprinet's Bid For Cellularline Fulfilled
Brief: Esprinet Unit To Launch Roadshow For Institutional Investors Of Cellularline
Brief: Esprinet H1 Net Profit Down To EUR 18.0 Million
Brief: 4 SIDE says Italy's Watchdog Approves Offer Document To Buy Cellularline
Brief: Italy's Watchdog Reopens Terms For Approval Of 4 SIDE's Takeover Bid On Cellularline
Brief: 4SIDE Says Italy's Watchdog Requests Suspension Of Review Period In Bid For Esprinet
Brief: Cellularline Contests Esprinet's Assessment Of Its Captal Assets' Impairment In Relation To Takevover Bid
Brief: Esprinet Completes Due Diligence, Launches Bid On Cellularline At 3.75 EUR/Shr
Brief: Esprinet Says Limited Due Diligence On Cellularline Is Still In Progress
Brief: Cellularline Allows Esprinet To Start Limited Due Diligence Activities
Brief: Esprinet Receives Approval To Carry Out Limited Due Diligence In Relation To Voluntary Public Tender Offer On Cellularline Shares
Brief: Cellularline To Carry Out Limited Due Diligence In Relation To Esprinet Voluntary Public Tender Offer
Brief: Esprinet Q1 Net Profit Down To EUR 10.1 Mln
Brief: Cellularline Says Board Of Directors Met To Examine Non-Binding Letter Of Intent Of Esprinet S.P.A.
Brief: Esprinet Says Submits To Cellularline's Board A Non-Binding Letter Of Intent Aimed At Launching A Public Tender Offer
Brief: Esprinet Shareholders' Meeting Approves Distribution Of EUR 0.54/Share Dividend
Brief: Esprinet FY Net Profit Up to EUR 44.2 Mln